Back
Open Access

How evidence from routine clinical practice can improve the care of the elderly atrial fibrillation patient?

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Treatment
Session type: Industry Q&A session
Sponsored by Daiichi Sankyo Europe GmbH
Date: 30 August 2020
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

0
6 presentations in this session

Welcome and introduction.

Speaker: Professor R. De Caterina (Pisa, IT)
Access
Video
0
Thumbnail

How routine clinical practice data should supplement the results from clinical trials?

Speaker: Professor G. Lip (Liverpool, GB)
Access
Video
0
Thumbnail

New insights from the ETNA-AF registry – focus on difficult-to-treat and comorbid patients.

Speaker: Professor J. De Groot (Amsterdam, NL)
Access
Video
0
Thumbnail

Optimisation of the anticoagulation management for elderly atrial fibrillation patients.

Speaker: Professor J. Steffel (Zurich, CH)
Access
Video
0
Thumbnail

Panel discussion.

Speaker: Professor R. De Caterina (Pisa, IT)
Speaker: Professor P. Kirchhof (Hamburg, DE)
Access
Video
0
Thumbnail

Conclusions.

Speaker: Professor P. Kirchhof (Hamburg, DE)
Access
Video
0
Thumbnail

7 speakers from this session

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
26 presentations
1 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
3 followers

Professor Joris R De Groot

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
10 presentations
2 followers

Professor Jan Steffel

Swiss EP AG, Zurich (Switzerland)
57 presentations
8 followers

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
26 presentations
1 follower

Professor Paulus Kirchhof

University Heart & Vascular Center Hamburg, Hamburg (Germany)
43 presentations
1 follower

Professor Paulus Kirchhof

University Heart & Vascular Center Hamburg, Hamburg (Germany)
43 presentations
1 follower

This platform is supported by

logo Novo Nordisk